Gene · 8019
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BRD4-targeting PROTAC as a unique tool to study biomolecular condensates. | Cell Discov | 2023 | 37156794 | PubTator, text mining | PubMed |
| Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity. | Neoplasia | 2023 | 37148657 | PubTator, text mining | PubMed |
| Targeting bromodomain-containing proteins: research advances of drug discovery. | Mol Biomed | 2023 | 37142850 | PubTator, text mining | PubMed |
| Targeting Myc-driven stress addiction in colorectal cancer. | Drug Resist Updat | 2023 | 37119690 | PubTator, text mining | PubMed |
| Inhibition of BET Proteins Regulates Fcγ Receptor Function and Reduces Inflammation in Rheumatoid Arthritis. | Int J Mol Sci | 2023 | 37108786 | PubTator, text mining | PubMed |
| Bromodomain and Extraterminal Domain (BET) Protein Inhibition Hinders Glioblastoma Progression by Inducing Autophagy-Dependent Differentiation. | Int J Mol Sci | 2023 | 37108181 | PubTator, text mining | PubMed |
| A desert lncRNA HIDEN regulates human endoderm differentiation via interacting with IMP1 and stabilizing FZD5 mRNA. | Genome Biol | 2023 | 37095549 | PubTator, text mining | PubMed |
| Selective degradation of cellular BRD3 and BRD4-L promoted by PROTAC molecules in six cancer cell lines. | Eur J Med Chem | 2023 | 37084596 | PubTator, text mining | PubMed |
| High-content synaptic phenotyping in human cellular models reveals a role for BET proteins in synapse assembly. | Elife | 2023 | 37083703 | PubTator, text mining | PubMed |
| The expanding universe of NUTM1 fusions in pediatric cancer. | Clin Transl Sci | 2023 | 37082775 | PubTator, text mining | PubMed |
| Rapid Elaboration of Fragments into Leads Applied to Bromodomain-3 Extra-Terminal Domain. | J Med Chem | 2023 | 37071570 | PubTator, text mining | PubMed |
| BRD4: New hope in the battle against glioblastoma. | Pharmacol Res | 2023 | 37061146 | PubTator, text mining | PubMed |
| Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells. | Clin Epigenetics | 2023 | 37060086 | PubTator, text mining | PubMed |
| BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications. | Molecules | 2023 | 37049806 | PubTator, text mining | PubMed |
| HAT1: Landscape of Biological Function and Role in Cancer. | Cells | 2023 | 37048148 | PubTator, text mining | PubMed |
| Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis. | Sci Adv | 2023 | 37043564 | PubTator, text mining | PubMed |
| Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens. | Proc Natl Acad Sci U S A | 2023 | 37036970 | PubTator, text mining | PubMed |
| Case report of a pan-cytokeratin negative NUT midline carcinoma of pulmonary origin, a BRD3-NUT variant: Challenges in cytomorphologic presentation. | Diagn Cytopathol | 2023 | 37021735 | PubTator, text mining | PubMed |
| Tracking chromatin state changes using nanoscale photo-proximity labelling. | Nature | 2023 | 37020029 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8019/papers?page=13